Segment and Related Information | Segment and Related Information Our operations are managed by senior executives who report to our Chief Executive Officer, the chief operating decision maker. Discrete financial information is available for each of the segments. The Chief Executive Officer uses EBITDA as the primary measure for reviewing the profitability of our segments and allocating resources to the segments. We define EBITDA as earnings from continuing operations before interest, income taxes, and depreciation and amortization. The activities of each of our segments from which they earn revenues and incur expenses are described below: • Olefins and Polyolefins-Americas (“O&P-Americas”). Our O&P-Americas segment produces and markets olefins and co-products, polyethylene and polypropylene. • Olefins and Polyolefins-Europe, Asia, International (“O&P-EAI”). Our O&P-EAI segment produces and markets olefins and co-products, polyethylene and polypropylene. • Intermediates and Derivatives (“I&D”). Our I&D segment produces and markets propylene oxide and its derivatives, oxyfuels and related products, and intermediate chemicals such as styrene monomer and acetyls. • Advanced Polymer Solutions (“APS”) . Our APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders. • Refining . Our Refining segment refines heavy, high-sulfur crude oil and other crude oils of varied types and sources available on the U.S. Gulf Coast into refined products, including gasoline and distillates. • Technology . Our Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts. “Other” includes intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other post-retirement benefit costs other than service costs. Sales between segments are made at prices approximating prevailing market prices. Summarized financial information concerning reportable segments is shown in the following tables for the periods presented: Year Ended December 31, 2024 O&P - O&P - I&D APS Refining Technology Other Total Millions of dollars Sales and other operating revenues: Customers $ 7,619 $ 10,188 $ 10,219 $ 3,616 $ 8,080 $ 580 $ — $ 40,302 Intersegment 3,914 679 205 18 479 91 (5,386) — 11,533 10,867 10,424 3,634 8,559 671 (5,386) 40,302 Less: Cost of sales 9,261 10,529 9,208 3,271 8,639 211 (5,381) 35,738 Impairments — 892 2 55 — — — 949 (Income) loss from equity investments (13) 217 13 — — — — 217 Gain on sale of business — — (284) — — — — (284) Other items 459 440 222 344 130 123 30 1,748 Add: Depreciation and amortization expense 619 220 401 90 150 42 — 1,522 EBITDA $ 2,445 $ (991) $ 1,664 $ 54 $ (60) $ 379 $ (35) $ 3,456 Capital expenditures $ 635 $ 525 $ 445 $ 105 $ 31 $ 95 $ 3 $ 1,839 Year Ended December 31, 2023 Millions of dollars O&P - O&P - I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 6,967 $ 9,822 $ 10,875 $ 3,686 $ 9,179 $ 578 $ — $ 41,107 Intersegment 4,313 657 211 12 535 85 (5,813) — 11,280 10,479 11,086 3,698 9,714 663 (5,813) 41,107 Less: Cost of sales 9,146 10,165 9,383 3,393 9,357 210 (5,805) 35,849 Impairments 25 38 192 252 11 — — 518 (Income) loss from equity investments (49) 55 13 1 — — — 20 Other items 442 437 262 312 125 119 48 1,745 Add: Depreciation and amortization expense 587 207 443 98 158 41 — 1,534 EBITDA $ 2,303 $ (9) $ 1,679 $ (162) $ 379 $ 375 $ (56) $ 4,509 Capital expenditures $ 480 $ 273 $ 590 $ 75 $ 32 $ 69 $ 12 $ 1,531 Year Ended December 31, 2022 Millions of dollars O&P - O&P - I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 9,420 $ 12,568 $ 12,703 $ 4,197 $ 10,975 $ 588 $ — $ 50,451 Intersegment 5,060 887 247 5 918 105 (7,222) — 14,480 13,455 12,950 4,202 11,893 693 (7,222) 50,451 Less: Cost of sales 11,953 12,943 11,135 3,901 10,883 242 (7,210) 43,847 Impairments — 69 — — — — — 69 (Income) loss from equity investments (98) 68 25 — — — — (5) Other items 351 368 250 281 128 124 4 1,506 Add: Depreciation and amortization expense 591 171 332 95 39 39 — 1,267 EBITDA $ 2,865 $ 178 $ 1,872 $ 115 $ 921 $ 366 $ (16) $ 6,301 Capital expenditures $ 383 $ 349 $ 940 $ 60 $ 53 $ 98 $ 7 $ 1,890 Other items include Selling, general and administrative expenses, Research and development expenses, and Other income (expense), net. A reconciliation of EBITDA to Income from continuing operations before income taxes is shown in the following table for each of the periods presented: Year Ended December 31, Millions of dollars 2024 2023 2022 EBITDA: Total segment EBITDA $ 3,491 $ 4,565 $ 6,317 Other EBITDA (35) (56) (16) Less: Depreciation and amortization expense (1,522) (1,534) (1,267) Interest expense (481) (477) (287) Add: Interest income 150 129 29 Income from continuing operations before income taxes $ 1,603 $ 2,627 $ 4,776 The following assets are summarized and reconciled to consolidated totals in the following table: Millions of dollars O&P - O&P - I&D APS Refining Technology Total December 31, 2024 Property, plant and equipment, net $ 6,592 $ 1,553 $ 5,670 $ 655 $ — $ 596 $ 15,066 Equity investments 2,011 1,732 377 1 — — 4,121 Goodwill 472 355 209 517 — 8 1,561 December 31, 2023 Property, plant and equipment, net $ 6,441 $ 2,139 $ 5,654 $ 678 $ 122 $ 513 $ 15,547 Equity investments 2,049 1,513 343 2 — — 3,907 Goodwill 477 380 215 567 — 8 1,647 Long-lived assets include Property, plant and equipment, net, Intangible assets, net and Equity investments, see Notes 7 and 8 to the Consolidated Financial Statements. The following long-lived assets data is based upon the location of the assets: December 31, Millions of dollars 2024 2023 Long-lived assets: United States $ 14,456 $ 14,334 Germany 1,691 1,593 The Netherlands 784 879 Italy 399 389 Mexico 257 281 France 171 731 China 124 375 Other 1,882 1,513 Total $ 19,764 $ 20,095 Disposition of Ethylene Oxide & Derivatives (“EO&D”) Business— In May 2024, we sold our U.S. Gulf Coast-based EO&D business along with the production facilities located in Bayport, TX. The EO&D business was included in our I&D segment. In connection with the sale, we received cash proceeds of $689 million and recognized a pre-tax gain of $284 million in 2024. Houston Refinery Operations— In 2022 we announced our plan to exit the refining business as it was determined to be the best strategic and financial path forward for the Company. We commenced shutdown activities in January 2025 and anticipate our refinery exit will be substantially completed in the first quarter of 2025. Costs incurred for the planned exit from the refinery business are as follows: Year Ended December 31, Cumulative Millions of dollars 2024 2023 2022 2024 Accelerated lease amortization costs $ 38 $ 110 $ 91 $ 239 Personnel costs 35 76 64 175 Asset retirement obligation accretion 8 9 2 19 Asset retirement cost depreciation 80 139 30 249 Other charges 18 — — 18 Refinery exit costs $ 179 $ 334 $ 187 $ 700 As of December 31, 2024, cumulative refinery exit costs were $700 million. We expect to incur an additional $70 million in subsequent periods, primarily due to the accretion of liabilities recorded for asset retirement obligations. We estimate that over half of these remaining costs will be incurred in 2025, with the remainder incurred over the next four years. Impairments— In 2024, we recorded impairments totaling $949 million. This amount includes charges related to the impairment of assets in our O&P-EAI and APS segments of $892 million and $55 million, respectively. Impairment charges included in our O&P-EAI segment relate to assets included in our European strategic review and a Chinese joint venture of $837 million and $52 million, respectively. These impairment charges reflect challenging market conditions in these regions. Impairments included in our APS segment includes an impairment charge of $55 million driven by unfavorable market conditions which resulted in the loss of customers in our APS specialty powders business unit. In 2023, we recorded a non-cash impairment charge of $192 million related to our European PO Joint Venture, which is included in the operating results for our I&D segment. See Notes 7 and 8 to the Consolidated Financial Statements for additional information. Segment Structure Changes and Related Goodwill Impairment— Effective January 1, 2023, our Catalloy and polybutene-1 businesses were moved from our APS segment and reintegrated into our O&P-Americas and O&P-EAI segments. In connection with this change, we recognized a non-cash goodwill impairment charge of $252 million in our APS segment. See Note 7 to the Consolidated Financial Statements for additional information regarding the impairment charge. Disposition of Australian Facility— In the second quarter of 2022 we sold our ownership interest in our PP manufacturing facility located in Geelong, Australia, LyondellBasell Australia (Holdings) Pty Ltd, for consideration of $38 million. In connection with this sale, we assessed the assets of the disposal group for impairment and determined that the carrying value exceeded the fair value less costs to sell. As a result, we recognized a non-cash impairment charge in the second quarter of 2022 of $69 million in the operating results of our O&P-EAI segment. The fair value measurement for the disposal group was based on expected consideration and classified as Level 3 within the fair value hierarchy. The charge is reflected as Impairments in the Consolidated Statements of Income. |